Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Raha Eskandari"'
Autor:
Saghar Barati, Hossein Amini, Zargham Hossein Ahmadi, Alireza Dastan, Babak Sharif Kashani, Raha Eskandari, Farzaneh Dastan
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 42, Iss 2, Pp 139-144 (2023)
Background and aim: Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by the obstruction of the main pulmonary artery due to thrombosis and vascular remodeling. Regarding the need for anticoagulant therapy in CTEPH patients, this study
Externí odkaz:
https://doaj.org/article/1de54f1176f7456385fbd0521c6bbf9e
Autor:
Seyed Mohammad Reza Hashemian, Hamidreza Jamaati, Farima Khalili-Pishkhani, Soheil Roshanzamiri, Raha Eskandari, Navid Shafigh, Abbas Ahmadi, Farzaneh Dastan
Publikováno v:
Microbes, Infection and Chemotherapy, Vol 2 (2022)
Since the start of the COVID-19 pandemic, a large number of trials have examined the efficacy of various medications as potential treatments for COVID-19, but a promising therapeutic option is still missing and under investigation. Molnupiravir is an
Externí odkaz:
https://doaj.org/article/6a351ca419ae43528a26cb817fc992b2
Autor:
Farzaneh Dastan, Golnaz Afzal, Somayeh Ghadimi, Hamidreza Jamaati, Raha Eskandari, Mohammad Farzad Nazari, Sahar Yousefian, Seyed Mohammad Reza Hashemian, Ali Amir Savadkoohi, Payam Tabarsi
Publikováno v:
Microbes, Infection and Chemotherapy, Vol 2 (2022)
Coronavirus disease (COVID-19) pandemic has turned into one of the most considerable challenges worldwide. The optimal treatment strategy, particularly in severely ill patients, is still unrecognized. IgM-enriched immunoglobulin (Pentaglobin®, Biote
Externí odkaz:
https://doaj.org/article/0b69eb2f9ab74d8bad6c4f22251a2a04
Autor:
Hamidreza Jamaati, Raha Eskandari, Afshin Moniri, Roodabeh Haghgoo, Sahar Yousefian, Zahra Mirshafiei Langari, Mihan Pourabdollah Toutkaboni, Majid Marjani, Farzaneh Dastan, Payam Tabarsi
Publikováno v:
Journal of Pharmacy Practice and Research. 51:456-463
Publikováno v:
Tanaffos. 20(3)
Autor:
Payam, Tabarsi, Hossein, Vahidi, Ali, Saffaei, Seyed Mohammad Reza, Hashemian, Hamidreza, Jammati, Bahram, Daraei, Arash, Mahboubi, Farzad, Kobarfard, Majid, Marjani, Afshin, Moniri, Zahra, Abtahian, Atefeh, Abedini, Alireza, Eslaminejad, Jalal, Heshmatnia, Maryam Sadat, Mirenayat, Atefeh, Fakharian, Sharareh, Seifi, Mohsen, Sadeghi, Alireza, Dastan, Sara, Haseli, Seyed Alireza, Nadji, Raha, Eskandari, Sahar, Yousefian, Mohammad, Varahram, Alireza, Zali, Ali Akbar, Velayati, Farzaneh, Dastan
Publikováno v:
Iranian journal of pharmaceutical research : IJPR. 20(4)
Coronavirus disease -19 (COVID-19) pandemic, caused by SARS-CoV-2, has gradually spread worldwide, becoming a major public health event. This situation requires designing a novel antiviral agent against the SARS-CoV-2; however, this is time-consuming
Autor:
Bahram, Fariborz Farsad, Farzaneh, Dastan, Jamshid, Salamzadeh, Zahra, Moghadamnia, Raha, Eskandari, Fanak, Fahimi
Publikováno v:
Iranian Journal of Pharmaceutical Research : IJPR
Warfarin is a critical medication that is broadly used for the treatment and prevention of thromboembolic disorders. Due to warfarin’s narrow therapeutic index, it is crucial that patients follow an appropriate dosage regimen. Patient knowledge is
Autor:
Hamidreza, Jamaati, Farzaneh, Dastan, Zahra, Mirshafiei Langari, Roodabeh, Haghgoo, Raha, Eskandari, Majid, Marjani, Afshin, Moniri, Seyed Mohammadreza, Hashemian, Behrooz, Farzanegan, Atefeh, Abedini, Payam, Tabarsi, Ali Akbar, Velayati
Publikováno v:
Tanaffos
Background: Antimicrobial stewardship program is a comprehensive, longitudinal program designed to improve and measure the appropriateness of antimicrobial use while increasing patients' safety, decreasing cost of patients' care, and combating emergi
Autor:
Raha Eskandari, Hamidreza Jamaati, Payam Tabarsi, Saghar Barati, Afshin Moniri, Zahra Abtahian, Sara Haseli, Majid Marjani, Fatemeh Monjazebi, Ali Saffaei, Alireza Dastan, Abdolbaset Vahedi, Sahar Yousefian, Farzaneh Dastan
Publikováno v:
International Immunopharmacology
Highlights • Intravenous immunoglobulin (IVIg) administration was not effective in the management of severe COVID-19 cases. • Intravenous immunoglobulin (IVIg) administration did not improve the radiographing changes in severe COVID-19 cases. •